Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Indications for intravenous immunoglobulins].

Luc Mouthon1

  • 1Université Paris-Descartes, Faculté de Médecine, Service de Médecine Interne et Centre de Référence pour les Vascularites Nécrosantes et la Sclérodermie Systémique, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris. luc.mouthon@cch.aphp.fr

Presse Medicale (Paris, France : 1983)
|April 15, 2006
PubMed
Summary

Intravenous immunoglobulins (IgIV) modulate immune responses for autoimmune diseases, alloimmunization, and infections. This review explores IgIV

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Moderators of Loneliness Trajectories in People with Systemic Sclerosis During the COVID-19 Pandemic: A SPIN COVID-19 Cohort Longitudinal Study.

International journal of behavioral medicine·2024
Same author

Authors reply: Clinical presentation, course, and prognosis of patients with mixed connective tissue disease.

Journal of internal medicine·2024
Same author

Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data.

Autoimmunity reviews·2023
Same author

Interstitial lung disease phenotype in mixed, differentiated, or overlapping, connective tissue diseases: Comment on the article by Boleto et al.

Seminars in arthritis and rheumatism·2023
Same author

Clinical presentation, course, and prognosis of patients with mixed connective tissue disease: A multicenter retrospective cohort.

Journal of internal medicine·2023
Same author

Takotsubo syndrome occurring in systemic diseases: A French multicenter retrospective case-control study and literature review.

Autoimmunity reviews·2023

Area of Science:

  • Immunology
  • Pharmacology
  • Rheumatology

Background:

  • Intravenous immunoglobulins (IgIV) are derived from pooled plasma of over 1000 healthy donors.
  • IgIV is a therapeutic preparation of polyclonal human IgG.
  • This article focuses on recognized and evaluated indications for IgIV in autoimmune and inflammatory diseases.

Purpose of the Study:

  • To discuss current and emerging applications of IgIV in treating autoimmune and systemic inflammatory conditions.
  • To explore IgIV's immunomodulatory mechanisms through specific disease examples.
  • To provide perspectives on future IgIV utilization.

Main Methods:

  • Review of recognized (Group I) and evaluated (Group II) indications for IgIV.
  • Case-based analysis of three distinct diseases demonstrating different immune modulation models.
  • Discussion of IgIV's role in autoimmune reactions, alloreactivity, and anti-infectious immunity.

Main Results:

  • Ocular cicatricial pemphigoid serves as a model for modulating autoimmune reactions.
  • Alloimmunization in chronic hemodialysis patients illustrates modulation of alloreactivity.
  • Streptococcal toxic shock demonstrates potential modulation of anti-infectious immunity.

Conclusions:

  • IgIV offers diverse immunomodulatory capabilities applicable to a range of conditions.
  • The therapeutic potential of IgIV extends beyond autoimmune diseases to alloimmunization and infections.
  • Further research into IgIV's mechanisms can expand its clinical applications.

Related Experiment Videos